Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
- M. Leach, K. Brindle, +18 authors P. Workman
- Medicine
- British Journal of Cancer
- 3 May 2005
Vascular and angiogenic processes provide an important target for novel cancer therapeutics. Dynamic contrast-enhanced magnetic resonance imaging is being used increasingly to noninvasively monitor… Expand
Imaging biomarker roadmap for cancer studies
- J. O’Connor, E. Aboagye, +74 authors J. C. Waterton
- Medicine
- Nature Reviews Clinical Oncology
- 11 October 2016
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used daily in oncology include clinical TNM stage, objective response and left ventricular ejection… Expand
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging.
- S. Galbraith, R. Maxwell, +7 authors G. J. Rustin
- Medicine
- Journal of clinical oncology : official journal…
- 1 August 2003
PURPOSE
Combretastatin A4 phosphate (CA4P) is a novel vascular targeting agent. Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) studies were performed to examine changes in parameters… Expand
Evaluation of the anti‐vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI
- R. Maxwell, J. Wilson, +4 authors G. Tozer
- Chemistry, Medicine
- NMR in biomedicine
- 1 April 2002
The anti‐vascular effects of the tubulin binding agent, disodium combretastatin A‐4 3‐O‐phosphate (CA‐4‐P), have been investigated in the rat P22 carcinosarcoma by measurements of radiolabelled… Expand
An assessment of 31P MRS as a method of measuring pH in rat tumours
- M. Stubbs, Z. M. Bhujwalla, +5 authors J. Griffiths
- Chemistry, Medicine
- NMR in biomedicine
- 1 November 1992
The contribution of extracellular components to the measurement of pHMRS of a variety of rat tumours (nitrosomethyl urea induced mammary tumours, GH3 prolactinomas, Hepatoma 9618a, UA hepatomas and… Expand
A comparison of DNA damage in testicular and proximal epididymal spermatozoa in obstructive azoospermia.
- E. K. Steele, N. McClure, R. Maxwell, S. Lewis
- Biology, Medicine
- Molecular human reproduction
- 1 September 1999
Testicular and epididymal spermatozoa are used routinely for intracytoplasmic sperm injection (ICSI) to treat men with obstructive azoospermia. Little is known of the effects of obstruction and… Expand
Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
- E. Aboagye, R. Maxwell, +6 authors P. Workman
- Medicine
- Cancer research
- 1 August 1997
A novel probe, N-(2-hydroxy-3,3,3,-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554), has been used to detect tumor hypoxia noninvasively by 19F magnetic resonance spectroscopy (19F MRS).… Expand
Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging
- B. Vormoor, Henrike K. Knizia, +10 authors C. Bacon
- Medicine
- PloS one
- 7 January 2014
Ewing sarcoma and osteosarcoma represent the two most common primary bone tumours in childhood and adolescence, with bone metastases being the most adverse prognostic factor. In prostate cancer,… Expand
Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopy.
- B. Seddon, R. Maxwell, +4 authors P. Workman
- Biology, Medicine
- Clinical cancer research : an official journal of…
- 1 July 2002
PURPOSE
Tumor hypoxia is associated with poor prognosis and a more malignant tumor phenotype. SR-4554, a fluorinated 2-nitroimidazole, is selectively bioreduced and bound in hypoxic cells. We present… Expand
Automated multi-residue isolation of fluoroquinolone antimicrobials from fortified and incurred chicken liver using on-line microdialysis and high-performance liquid chromatography with programmable…
- E. Cohen, R. Maxwell, D. J. Donoghue
- Chemistry, Medicine
- Journal of chromatography. B, Biomedical sciences…
- 5 March 1999
Isolation of the quinolones, sarafloxacin (SAR), oxolinic acid (OXA), and flumequine (FMQ), from fortified chicken liver tissues, and SAR incurred chicken liver tissues was achieved by combined… Expand